MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
39.35
+3.84 (10.81%)
Jun 15, 2026, 12:54 PM EDT - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.87 billion as of June 15, 2026. Its market cap has increased by 351.17% in one year.
Market Cap
1.87B
Enterprise Value
1.25B
1-Year Change
351.17%
Ranking
Category
Stock Price
$39.35
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.87B, an increase of 267.49%. That is a compound annual growth rate of 110.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.87B | 32.25% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.75B |
| uniQure | 1.74B |
| Nuvation Bio | 1.71B |
| Biohaven | 1.70B |
| Intellia Therapeutics | 1.69B |
| Innoviva | 1.68B |
| Recursion Pharmaceuticals | 1.67B |
| Zymeworks | 1.67B |